Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Insulin receptor splicing alteration in myotonic dystrophy type 2
R. S. Savkur
, A. V. Philips
, T. A. Cooper
, J. C. Dalton
,
M. L. Moseley
, L. P.W. Ranum
, John W. Day
Genetics, Cell Biology and Development (TMED)
Research output
:
Contribution to journal
›
Article
›
peer-review
140
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Insulin receptor splicing alteration in myotonic dystrophy type 2'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Myotonic Dystrophy
100%
Myotonic Dystrophy Type 2
100%
Insulin Receptor
100%
Splicing Alteration
100%
Repeat Expansion
40%
Diabetes
20%
Mouse Model
20%
Dysregulation
20%
Nonmuscle
20%
RNA-binding Protein
20%
Species Differences
20%
Muscle Pathology
20%
3′-untranslated Region (3′-UTR)
20%
Chromosome 3
20%
DMPK Gene
20%
Insulin Deficiency
20%
RNA Splicing
20%
Chromosome 19
20%
ZNF9
20%
Tetranucleotide Repeats
20%
Splicing Abnormality
20%
CTG Expansion
20%
Pathogenic Effects
20%
Neuroscience
Myotonic Dystrophy
100%
Insulin Receptor
100%
Untranslated Region
33%
Alternative Splicing
33%
Histopathology
33%
Intron
33%
Chromosome 19
33%
Chromosome 3
33%
RNA-binding Protein
33%
Nucleus
33%
Biochemistry, Genetics and Molecular Biology
Insulin Receptor
100%
Isoform
33%
Mouse Model
33%
RNA
33%
RNA-binding Protein
33%
Insulin Sensitivity
33%
Intron
33%
Chromosome 3
33%
Untranslated Region
33%
Alternative Splicing
33%
Species Difference
33%
Chromosome 19
33%